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Abstract
Deletion of glucose transporter gene Slc2a3 (GLUT3) has
previously been reported to result in embryonic lethality.
Here, we deﬁne the exact time point of growth arrest and
subsequent death of the embryo. Slc2a3
K/K morulae and
blastocysts developed normally, implanted in vivo, and formed
egg-cylinder-stage embryos that appeared normal until day
6.0. At day 6.5, apoptosis was detected in the ectodermal cells
of Slc2a3
K/K embryos resulting in severe disorganization and
growth retardation at day 7.5 and complete loss of embryos at
day 12.5. GLUT3 was detected in placental cone, in the
visceral ectoderm and in the mesoderm of 7.5-day-old wild-
type embryos. Our data indicate that GLUT3 is essential for
the development of early post-implanted embryos.
Journal of Endocrinology (2009) 200, 23–33
Introduction
The glucose transporter family comprises 14 members,
GLUT1–12, GLUT14 and HMIT1 (H
C/myo-inositol sym-
porter; Joost & Thorens 2001, Scheepers et al.2 0 0 4 ). GLUT3
exhibits a high afﬁnity for glucose (KmZ1.8 mM) and was
identiﬁed as the neuronal glucose transporter primarily located
in axons and dendrites (Mantych et al.1 9 9 2 , Nagamatsu et al.
1992, McCall et al. 1994, Vannucci et al.1 9 9 7 , Simpson et al.
2008). Expression of GLUT3 coincides with maturation and
regional cerebral glucose utilization (Vannucci et al. 1998).
However,deletionofoneSlc2a3alleledidnotalter maintenance
ofneuronalenergysupply,motorabilities,learning,andmemory
in mice (Schmidt et al. 2008). By contrast, heterozygous
disruption of the blood–brain barrier glucose transporter
GLUT1 in Slc2a1
C/K mice resulted in a dramatic phenotype
with microencephaly, impaired motor activity, cerebral ataxia,
and multiple spontaneous cortical seizures (Wang et al. 2006).
GLUT3 is also expressed in other cells (sperm, pre- and
post-implantation embryo circulating white blood cells, and
carcinoma cells) where it triggers the speciﬁc requirements for
glucose(Simpsonet al.20 08 ).Severalstudieshavedemonstrated
that GLUT3 is crucial for the optimal development of the
embryo (Pantaleon et al. 1997, Moley et al. 1998, Simpson et al.
2008, Wyman et al. 2008). Until compaction ofthemorula, the
mammalian embryo derives energy from pyruvate and lactate
(Barbehennetal.1974).Theswitchtometabolizeglucoseasthe
primaryenergysourcecoincideswiththeexpressionofGLUT3
from the late cleavage stages onward (Mantych et al. 1992).
During early mouse embryogenesis, the expression of seven
GLUTisoformshasbeendescribed.GLUT1andGLUT9were
foundin all pre-implantationstages, GLUT2andGLUT3 were
detectedattheeight-cellstage(Hoganetal.1991,Pantaleonetal.
1997), and GLUT4 and GLUT8 at the blastocyst stage and
thereafter (Hogan et al.1 9 9 1 , Aghayan et al.1 9 9 2 , Carayanno-
poulosetal.2004).Bycontrast,GLUT12hasonlybeendetected
at the eight-cell stage of the pre-implanted embryo (Zhou et al.
2004). Thus, the trophectodermic GLUT3 appeared the main
glucose transporter responsible for the uptake of maternal
glucose into the blastocyst. Its apical localization in the
trophectoderm provides theinnercell mass (ICM) with glucose
together with the basolateral GLUT1 (Pantaleon et al.1 9 9 7 ,
Pantaleon & Kaye 1998). Downregulation of GLUT3
expression with antisense oligonucleotides resulted in a marked
reductionofglucoseuptakeandina50%decreaseinthenumber
of embryos progressing to blastocyst stage. These data indicated
that expression of the high-afﬁnity transporter GLUT3
correlates with the switch to a metabolic preference for glucose
versuspyruvate(Pantaleonetal.1997).Similardefectsinembryo
development were observed in mice in which diabetes mellitus
was induced by streptozotocin. GLUT3 expression was down-
regulated in the blastocysts (Moley et al. 1998). In addition,
in vitro culture in high glucose concentration induced a
downregulation of GLUT3 and an intrauterine growth
retardation after transfer of blastocysts into recipient mice
(Wyman et al.2 0 0 8 ).
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gene in mice leads to embryonic lethality. Slc2a3
K/K
embryos were detected at the blastocyst stage but displayed
increased apoptosis and delayed development. However,
despite cell death, Slc2a3
K/K embryos implanted but were
lost at embryonic day 8.5( Ganguly et al. 2007). Here, we
describe the exact time point of embryonic lethality, and
identify the defect responsible for death of post-implanted
embryos. We show that disruption of GLUT3 expression has
no effect on blastocyst development, but arrests embryonic
development at day 6.5 correlating with initiation of
apoptosis in ectodermic cells.
Materials and Methods
Inactivation of the Slc2a3 gene
For the generation of Slc2a3 knockout mice, we used the ES
cell clone XG611 (Bay Genomics, San Francisco, CA, USA).
The clone was tested for a single integration event of the gene
trap vector in the Slc2a3 gene (see below). ES cells of clone
XG611 were injected into blastocysts that were implanted
into pseudopregnant females. Chimeras were mated with
C57BL/6 mice, and F1 progeny carrying the transgene were
backcrossed ﬁve times onto the C57BL/6 background.
Genotyping of blastocysts, embryos, and mice was performed
by PCR (for wild-type allele, forward primer: 50-CCCTG-
CATTCACCGTTCC-30, reverse primer: 50-GATGACTC-
CAGTGTTGTAGC-30; for knockout allele, forward
primer: 50-GCAGATCGCATCGATAACTTCG-30, reverse
primer: 50-AGTATCGGCCTCAGGAAGATCG-30). The
animals were housed in air-conditioned rooms (temperature
20G2 8C, relative moisture 50–60%) under a 12 h light:12 h
darkness cycle. They were kept in accordance with the UK
legal requirements for the care and use of laboratory animals,
and all experiments were approved by the ethics committee of
the Ministry of Agriculture, Nutrition and Forestry (State of
Brandenburg, Germany).
RNA preparation, ﬁrst-strand cDNA synthesis, and sequencing
EScellsfromcloneXG611wereharvestedforRNApreparation
asdescribed(Gawliketal.2008).PrimersspeciﬁcforGLUT3or
b-geocassetteusedinthePCRwereasfollows:forwardprimer
(f1): 50-ATGCTTTCGGTGATAGTCCTT-30; forward
primer (f2): 50-AGGAACACTTGCTGCCGAGA-30;r e v e r s e
primer (r1): 50-AGTATCGGCCTCAGGAAGATCG-30;a n d
reverse primer (r2): 50-ATTCAGGCTGCGCAACTG-
TTGGG-30.
Southern blotting
Genomic DNA of ES cell clone XG611 was digested with
either BglII or NcoI, separated on a 0.7% agarose gel, and
blotted onto a Hybond-N
C-nylon membrane (Amersham
Pharmacia Biotech). To verify a single recombination of the
gene trap vector in the ES cell clone, a 722 bp PCR fragment
(forward primer: 50-TTATCGATGAGCGTGGTGGT-
TATGC-30, reverse primer: 50-GCGCGTACATCGGG-
CAAATAATATC-30) of the b-geo cassette of the gene trap
vector was used as a probe for hybridization after labeling with
[a
32P]dCTP with a random priming kit (Amersham
Pharmacia Biotech).
Embryo recovery and culture
Eight- to ten-week-old GLUT3 heterozygous mice were
intercrossed overnight. Matings were conﬁrmed by the
identiﬁcation of a vaginal plug in the next morning. For
immunohistochemical characterization of blastocysts, the
animals were killed on embryonic day 3.5 (E3.5 dpc), and
embryos were obtained by ﬂushing the uterine horns and
cultured under mineral oil at 37 8C in a humidiﬁed
atmosphere of 5% CO2 in DMEM high glucose/Na-pyruvate
medium (PAA Laboratories, Linz, Austria) containing 10%
FCS (PAN, Aidenbach, Germany). For analysis of outgrowth,
blastocysts were cultured in M2 medium (Sigma). For the
characterization of the development of morulae to blastocysts,
one-cell-stage embryos (E0.5 dpc) were isolated and cultured
until day 2.5o r3 .5 dpc (morula or early blastocyst stage,
respectively). Thereby one-cell-stage embryos were incu-
bated in M2 medium (Sigma) containing 0.5m g / m l
hyaluronidase (Sigma). In order to remove the cumulus
cells, the embryos were washed several times in M2 medium
before cultivation in DMEM high glucose/Na-pyruvate
medium (PAA Laboratories) containing 10% FCS (PAN).
Immunostaining of blastocysts
Goat anti-GLUT3 antibody (Zhou et al. 2002) was obtained
from Santa Cruz Biotechnology Inc. (M20; Santa Cruz, CA,
USA). Additional stainings of GLUT3 were performed with a
polyclonal anti-GLUT3 antibody described by Hellwig et al.
(1992). The anti-GLUT1 antibody was described previously
(Hellwig et al. 1992). Results were conﬁrmed with an
additional rabbit anti-GLUT1 antibody (Ogawa et al. 2007)
purchased from Santa Cruz (H43). Blastocysts were ﬁxed in
3% paraformaldehyde, permeabilized with 0.2% saponin
(Sigma) in PBS containing 0.1% PVP for 30 min, and blocked
with antibody diluent (DakoCytomation, Carpinteria, CA,
USA). Blastocysts were incubated with the primary and
secondary antibodies. Nuclei and cytoskeleton were counter-
stained. Fluorescence was detected with laser scanning
confocal immunoﬂuorescent microscopy (Leica TCS SP2
system; Leica, Mannheim, Germany). Genotypes of blas-
tocysts were determined by PCR thereafter. Therefore,
blastocysts were reincubated with water and proteinase k
supplemented PCR buffer and PCR was performed as
described above.
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For histological analysis, uteri were isolated at embryonic days
6.0, 6.5, and 7.5 post-coitum and ﬁxed in 4% paraformalde-
hyde for 24 h, dehydrated, and embedded in parafﬁn. Serial
sections(2 mm) weregenerated from thewhole embryo(w16
sections of 6.5-day-old embryo) and stained with hematox-
ylin and eosin or stained for GLUT3, GLUT1, and activated
caspase 3 (Cell Signaling Technology Inc., Beverly, MA,
USA), for E-cadherin (clone HECD-1 in a dilution of 1:400)
and for N-cadherin (1:500; Zymed, South San Francisco,
CA, USA), or MKI67 (1:50; DakoCytomation, Glostrup,
Denmark).
Results
Disruption of the Slc2a3 gene
For the generation of conventional GLUT3 knockout mice
(Slc2a3
K/K), we used a gene trap ES cell clone (clone
XG611). Insertion of the gene trap vector into intron 1 of
Slc2a3 (Fig. 1A) resulted in a fusion protein consisting of ﬁve
amino acids of GLUT3, neomycin phosphotransferase, and
b-galactosidase. Correct integration of the gene trap vector
into the Slc2a3 gene was veriﬁed by PCR (Fig. 1B). Sequence
analysis of the PCR products indicated correct splicing of
exon 1 to the splice acceptor site of the gene trap vector (data
not shown). Digestion of genomic DNA from clone XG611
w i t he i t h e rB g l I Io rN c o Ia n dh y b r i d i z a t i o nw i t ha
b-galactosidase-speciﬁc probe resulted in single bands,
indicating that the gene trap vector was integrated only
once into the ES cell genome (Fig. 1B, right panel). For the
generation of Slc2a3
K/K mice, ES cells of clone XG611 were
injected into blastocysts that were implanted into pseudo-
pregnant females. Chimeras were mated with C57BL/6 mice,
and F1 progeny carrying the transgene were backcrossed ﬁve
times onto the C57BL/6 background.
Embryonic lethality of Slc2a3
K/K mice prior to ED 12.5
Homozygous disruption of the Slc2a3 gene resulted in
embryonic lethality, since only Slc2a3
C/C and Slc2a3
C/K but
no Slc2a3
K/K mice could be genotyped after birth (Table 1).
Approximately,twiceasmanySlc2a3
C/KthanSlc2a3
C/Cmice
wereborn,indicatingthatSlc2a3
C/Kmicehadnodisadvantage
in embryonic development. In order to narrow down the time
point at which disruption of Slc2a3 was lethal, embryos were
isolated and genotyped at E12.5 dpc. Out of 40 embryos
(5 litters) genotyped, no Slc2a3
K/K mutants were detected,
indicating that Slc2a3
K/K mice die early in gestation.
Disruption of Slc2a3 does not interfere with development of
blastocysts
In order to determine whether ablation of GLUT3 results
in an arrest of growth at the morula or blastocyst stage, 43
one-cell-stage embryos (0.5d p c )o fSlc2a3
C/K mice matings
(5 litters) were isolated and cultured until day 2.5o r3 .5p c
(morula or early blastocyst stage, respectively). The develop-
ment ofthe embryoswasdocumented by light microscopy, and
genotypes of embryos were determined by PCR thereafter.
Figure2illustratesthatSlc2a3
K/Kmorulaeandblastocystswere
indistinguishable from wild-type and Slc2a3
C/K genotypes.
Growth of pre-implanted embryos was monitored for 24 h
with blastocysts isolated from heterozygous matings at E3.5
dpc and individually cultured in vitro. From 10 litters, 25
Slc2a3
C/C,2 0Slc2a3
C/K, and 9 Slc2a3
K/K blastocysts were
obtained. The morphology of Slc2a3
K/K blastocysts
appeared normal with a proliferating ICM (Fig. 3A).
Immunostaining of blastocysts with either of two anti-
GLUT3 antibodies (middle panels) conﬁrmed that all
blastocysts genotyped as Slc2a3
K/K lacked the GLUT3
protein (Fig. 3A). By contrast, Slc2a3
C/C and Slc2a3
C/K
blastocysts showed intense immunoreactivity. Here, GLUT3
was restricted to the apical membranes of the polarized
epithelium (trophectoderm). In addition, staining for actin
cytoskeleton and nuclei did not show any abnormality of
Slc2a3
K/K blastocysts (Fig. 3, right panels). In order to test
the possibility of a compensatory increase or an altered
subcellular distribution of GLUT1 in Slc2a3
K/K blastocysts,
an additional set of 13 blastocysts (4 litters) was stained with
anti-GLUT1 antibody. GLUT1 immunoreactivity was
predominantly detected in the basolateral, but also in the
apical membranes of the trophectoderm and in the plasma
membranes of cells from the ICM. No differences between
Slc2a3
C/C, Slc2a3
C/K, and Slc2a3
K/K blastocysts were
detectable (Fig. 3B). The same result was obtained by a
second anti-GLUT1 antibody (H43) demonstrating that the
signals obtained by immunohistochemistry were speciﬁc (data
not shown).
In order to test whether extraembryonic components are
affected in the absence of Slc2a3, we analyzed the trophoblast
growth of isolated in vitro-cultivated embryos. As shown in
Supplementary Fig. 1, see Supplementary data in the online
version of the Journal of Endocrinology at http://joe.
endocrinology-journals.org/content/vol200/issue1/,n o
difference in the proliferation capacity of trophectodermal
cells was visible between wild-type, heterozygous, and
knockout embryos.
Deletion of GLUT3 results in embryonic lethality at the
gastrulation stage
In order to determine the exact time point of death of
Slc2a3
K/K mutants, uteri from heterozygous intercrosses
were analyzed at different days of gestation (E6.0, 6.5, and
7.5 dpc). Genotypes were identiﬁed by the immunostaining
of GLUT3. The distribution of the Slc2a3 alleles calculated
for all embryos corresponded exactly with the Mendelian
segregation, consistent with the conclusion that development
and implantation of blastocysts was not affected by disruption
of Slc2a3 (Table 2).
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organized ectoplacental cone, an extraembryonic and embryo-
nicectoderm,andavisceralendoderm(Fig.4A).Slc2a3
C/Cand
Slc2a3
C/K embryos were indistinguishable, with pronounced
immunoreactivity of GLUT3 in the ectoplacental cone and
visceral endoderm. Adjacent sections were stained for GLUT1,
whichwasdetectedinallembryoniccells(Fig.4A,rightpanels).
Again, no compensatory increase in GLUT1 was detected. At
E6.5d p c ,Slc2a3
K/K mutants started to exhibit microscopical
abnormalities in that the shape of cells within the ectoderm
differedfromthatofcontrolembryos.Theectodermalcelllayer
of the Slc2a3
C/C embryos composed of high columnar
epithelial cells, whereas cells of Slc2a3
K/K appeared round
and uniform (see arrows in Fig. 4B). Furthermore, staining of
embryos with an antibody against activated caspase 3-detected
apoptotic cells in the distal part of the embryonic ectoderm
(Fig. 4B). For quantiﬁcation, we stained sections of six control
and ﬁve knockout embryos in the area of the amniotic cavity
with the anti-caspase 3 antibody and counted the activated
caspase3-positivecells.Wedetected10.5G3.3apoptoticcellsin
6.5-day-oldSlc2a3
K/Kembryos,butnoapoptoticcellincontrol
embryos (Mann–Whitney U-test, P!0.0043). In addition, no
activated caspase 3-positive cells were obtained in E6.0d p c
embryos of both genotypes (data not shown). The number of
caspase-positive cells was markedly increased in Slc2a3
K/K
embryos examined 4–6 h later (Fig. 4B, right panel). At
E7.5 dpc, the developmentofSlc2a3
K/Kembryos was severely
Figure 1 Disruption of the Slc2a3 gene by gene trapping. (A) Localization of the gene trap between exons 1
and 2 of theSlc2a3gene.(B) Integration ofthe genetrapvector in intron1 ofthe Slc2a3gene inES cell clone
XG611 results in a fusion transcript containing exon 1 and the b-geo cassette. With the indicated primer
pairs, four speciﬁc RT-PCR products were detected. (C) Southern blot analysis conﬁrmed the single
integration of the gene trap vector into the Slc2a3 gene of clone XG611. Genomic DNA was digested with
BglII or NcoI and analyzed by Southern blotting with the indicated probe. A single 7 and 5.5 kb band
respectively was detected in each panel.
Table 1 Genotype distribution of progeny observed at weaning.
Tail biopsies were taken for genotyping by PCR as described in the
Materials and Methods section.
Number of
animals
Distribution
(%)
Expected
(%)
Genotype
Slc2a3
C/C 98 31 25
Slc2a3
C/K 215 69 50
Slc2a3
K/K 00 2 5
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were smaller than control embryos (mean length of Slc2a3
K/K
E7.5 dpc embryos, 600G30.9 mm; control embryos, 790.0G
51.0 mm). In addition, the number of proliferating cells in the
ectoplacentalconeandtheembryonicendodermwasreducedin
Slc2a3
K/Kembryos (Supplementary Fig. 2, see Supplementary
data in the online version of the Journal of Endocrinology
at http://joe.endocrinology-journals.org/content/vol200/
issue1/),supportingtheﬁnding of a marked growth retardation
and a cessation of embryonic development in the absence of
GLUT3. In addition, Slc2a3
K/K embryos appeared to be
disorganized. The higher magniﬁcation of HE-stained sections
of 7.5-day-old embryos showed a vacuolization of ectodermal
c e l l s( s e ea r r o w si nFig. 4C). These cells still expressed the
adhesionproteinE-cadherin,atthecellsurfaceandN-cadherin,
a marker for the mesoderm (Hatta & Takeichi 1986). Thus, the
Slc2a3
K/K embryos started to develop the third germ layer.
However, they did not develop the ectoplacental and
exocoelomic cavities that were visible in control embryos at
the age of 7.5 days. Instead, a condensed mass of cells was
located in the region adjacent to the ectoplacental cone that
contained a small amniotic cavity (Fig. 4C). By contrast, wild-
type primitive streak-stage embryos exhibited a well-organized
ectoderm, endoderm, and mesoderm, and had developed the
ectoplacental cone and ectoplacental, exocoelomic, and
amniotic cavities. Strikingly, GLUT3 immunoreactivity in
primitive streak-stage embryos was restricted to the visceral
endodermandmesoderm,whereastheearliestsignsofcelldeath
were detected in the ectodermal cells of Slc2a3
K/K embryos
(Fig. 4B).
Discussion
The present data indicate that the glucose transporter GLUT3
is essential for substrate supply of the developing embryo, but
not for the fertilization of oocytes or growth and implantation
of blastocysts. Blastocyst formation was not affected by the
absence of GLUT3 because Slc2a3
K/K blastocysts were
 
Figure 2 Identiﬁcation of Slc2a3
K/K morulae and early blastocysts. Zygotes were isolated and cultured until
the morula or early blastocyst stage, documented, and genotyped by PCR after lysis. PCR 1 generated a
product of 250 bp corresponding to the trapped allele (upper left), and PCR 2 generated a 500 bp product of
the wild-type allele (upper right). Images of a compacted morula (left) and an early blastocyst (right) of each
genotypeare shown togetherwith the result of a representative genotypingreaction. Fullcolourversion of this
ﬁgure available via http://dx.doi.org/10.1677/JOE-08-0262.
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C/C, Slc2a3
C/K, and Slc2a3
K/K blastocysts at
day 4.5 pc. Blastocysts were isolated and stained for (A) GLUT3 or (B) GLUT1 in combination with
an Alexa 488-labeled secondary antibody. Genotyping (left panels) was performed by PCR as
described in the legend of Fig. 2. Nuclei (blue) and actin cytoskeleton (red) were counterstained.
GLUT1 immunoreactivity is indicated by arrows.
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type blastocysts, GLUT3 was detected at the apical membrane
of the trophectoderm (Fig. 3), as already described earlier
(Pantaleon et al. 1997, Pantaleon & Kaye 1998), whereas
GLUT1 was predominantly present in the basolateral and, to
a smaller extent, in the apical membranes of the trophecto-
derm, and at the surface of cells from the ICM. This
observation is in contrast to the results described by Pantaleon
Figure 4 (continued)
Table 2 Genotype distribution of all embryos observed between embryonic days 6.0 and 7.5
Slc2a3
C/C and Slc2a3
C/K embryos Slc2a3
K/K embryos Total number of embryos
Embryonic day
6.06 3 9
6.51 7 6 2 3
7.52 4 8 3 2
Sum 6.0–7.54 7 1 7 6 4
Expected distribution (6.0–7.5) 48 16 64
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basolateral localization of GLUT1 in both morulae and
blastocysts. One reason for this discrepancy might be the
difference in the sensitivity of the anti-GLUT1 antibodies.
A second reason for the discrepancy in GLUT1 distribution
could be a difference in culture conditions, e.g., the glucose
concentration. We cultivated blastocysts in the presence of
4.5 g glucose/l, which might alter the rate of glycolysis and
thereby GLUT1 expression and/or localization. Several
parameters, for example, oxygen concentration (Harvey
et al. 2004), modify GLUT1 expression in blastocysts; also,
glucose concentration itself was described to change GLUT1
protein levels in parallel with the transport activity (von der
Crone etal. 2000) in other systems such as 3T3-L1 adipocytes.
Since ablation of GLUT1 (Wang et al. 2006) and also of
GLUT8 (Membrez et al. 2006, Gawlik et al. 2008) did not
affect implantation, blastocysts appear to be able to
compensate for a reduction in the glucose transport capacity.
This conclusion is in contrast to previous reports describing
that in vitro cultivation of zygotes or two-cell embryos in the
absence of glucose led to inhibition of blastocyst formation
(Brown & Whittingham 1992) or a reduced number of ICM
and trophectoderm cells (Brown & Whittingham 1991,
Luisier et al. 2001). However, consistent with our results,
Martin & Leese (1995) described that blastocysts developed
in vitro from two-cell embryos in the complete absence of
glucose, suggesting that pyruvate uptake can fully sustain the
energy supply for blastocyst development.
In the present study, the absence of GLUT3 failed to alter
expression or distribution of GLUT1 (Fig. 3B). By contrast,
Ganguly et al. (2007) detected GLUT1 exclusively at the
basolateral surface of wild-type blastocysts, at apical and
basolateral membranes of heterozygous blastocysts, and in a
scattered cytoplasmic distribution in Slc2a3
K/K blastocysts. In
addition, they detected Tunnel-positive, apoptotic cells in
Slc2a3
K/Kblastocysts,whereasSlc2a3
K/Kblastocystsappeared
healthy, and were able to grow in vitro and to implant into the
uterus in the present study. It is unclear whether differences in
thegeneticbackgroundorintheconditionsofblastocystculture
can account for these discrepant results. It should be noted,
however, that Ganguly et al. (2007) distinguished the wild-type
and Slc2a3
C/K blastocysts not by genotyping but through the
Figure 4 (continued)
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trophectoderm). Thus, the study lacks unambiguous proof that
the observed differences between wild-type and heterozygote
blastocysts are associated with the respective genotype.
The present data precisely identiﬁed the developmental
stage and time point at which disruption of Slc2a3 is lethal.
Slc2a3
K/K embryos appeared normal until day 6.0, exhibited
distinct morphological changes including apoptotic cells at
day 6.5, were arrested in growth at day 7.5, and were
completely lost at day 12.5 post-coitum. Ganguly et al. (2007)
had indirect evidence that failure of Slc2a3
K/K embryos
occurred at neurulation, which begins with neural tube
closure at embryonic day 8.5. They detected all three
genotypes (wild-type, heterozygous, and knockouts) at
embryonic day 8.5, but failed to ﬁnd knockout embryos
at day 9.5. According to our results Slc2a3
K/K, embryos at
day 8.5 were probably partially degraded. We discovered
events of apoptosis starting at E6.5 dpc and a marked growth
retardation and a cessation of development in the absence
of GLUT3 at E7.5 dpc. This is similar to other knockout
mice, e.g., the ZO2
K/K mutant (Xu et al. 2008)o r
Arfrp1
K/K mice (Mueller et al. 2002), in which apoptotic
events during gastrulation resulted in a loss of the embryos at
early time points.
Thus, lethality of Slc2a3
K/K embryos started at day 6.5b y
apoptosis of ectodermal cells. Two alternative hypotheses
might explain why ectodermal cells that do not express
GLUT3 undergo apoptosis. i) Defective placental develop-
ment of Slc2a3
K/K mice might be responsible for lethality of
the embryos. ii) Reduced substrate supply via visceral
endoderm that lack GLUT3 might arrest embryonic
development. The ﬁnding that in vitro-cultivated Slc2a3
K/K
embryos did not show defects in trophectoderm development
(Supplementary Fig. 1) might indicate that GLUT3 is a
Figure 4 Defective development and apoptotic cell death in Slc2a3 mutant embryos. Histological analysis of Slc2a3
K/K and control embryos
(eitherSlc2a3
C/CorSlc2a3
C/K).Serialsagittalsectionsofuterifromheterozygousmatingsat(A)day6.0,(B)6.5,and(C)7.5pcwerestainedwith
hematoxylin and eosin (HE), or used for staining of GLUT3, GLUT1, activated caspase 3, E-cadherin, or N-cadherin. ac, amniotic cavity; ec,
ectoplacental cavity; ecc, exocoelomic cavity; ee, embryonic ectoderm; eee extraembryonic ectoderm; em, embryonic mesoderm; en,
endoderm; epc, ectoplacental cone. Microscopical abnormalities in ectodermal cells of mutant embryos are indicated by arrowheads.
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endoderm, and that its disruption causes a deﬁciency in
ectodermal cells.
Several studies have linked a reduced glucose transport to
the initiation of apoptosis (Kan et al. 1994, Berridge et al.
1996). In the models of neuronal development and trophic
factor deprivation, a decrease in glucose uptake is one of the
earliest changes observed in the cascade of apoptosis (Johnson
et al. 1996).
In summary, deletion of GLUT3 in mice arrests early
embryonic development due to apoptosis of ectodermal cells
shortly after implantation (E6.5 dpc). By contrast, the
development of pre-implantation embryos is independent of
GLUT3.
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